SIM
SAGE

Sonora Investment Management’s Sage Therapeutics SAGE Stock Holding History

Sonora Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Hold
16
– – ﹤0.01% 1054
2021
Q2 		$1K Buy
+16
New +$1.13K ﹤0.01% 959

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sonora Investment Management's SAGE Position: Q3 2021 in Review

Sonora Investment Management held its Sage Therapeutics (SAGE) position steady in Q3 2021 at 16 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Sonora Investment Management first reported a position in SAGE in Q2 2021 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • Sonora Investment Management held 16 shares of Sage Therapeutics worth $1K as of Q3 2021.
  • Sonora Investment Management left its Sage Therapeutics share count unchanged in Q3 2021.
  • Sage Therapeutics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #1054 holding.
  • Sonora Investment Management first reported a position in Sage Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.